Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 242-255
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.242
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.242
Figure 2 Adeno-associated virus carrying thymosin β4 ameliorated dextran sulfate sodium-induced colitis in mice.
A: Dynamic changes in DAI [the asterisk indicates aP < 0.05 vs PBS/dextran sulfate sodium (DSS) or adeno-associated virus (AAV)-LacZ/DSS group]; B and C: AAV-thymosin β4 (Tβ4) improved DSS-induced colonic lesions including mucosal edema, hyperemia, and ulceration, resulting in a significantly decreased macroscopic score; D and E: Histological examination (HE staining, magnification × 200) revealed the mice in AAV-Tβ4/DSS group exhibited alleviated colonic lesions such as destruction of mucosal crypts, loss of epithelial cells, deep ulcerations, and inflammatory cell infiltration, leading to a significantly decreased histological score compared with the mice in the other two DSS groups. Error bars indicate the SD. Scale bars = 50 μm. DAI: Disease activity index.
- Citation: Zheng XY, Lv YF, Li S, Li Q, Zhang QN, Zhang XT, Hao ZM. Recombinant adeno-associated virus carrying thymosin β4 suppresses experimental colitis in mice. World J Gastroenterol 2017; 23(2): 242-255
- URL: https://www.wjgnet.com/1007-9327/full/v23/i2/242.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i2.242